The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial
Journal Title: Electronic Physician - Year 2017, Vol 9, Issue 11
Abstract
BACKGROUND: Different studies have been conducted to find the best adjuvant therapies for depression management. There are controversies over the effects of aspirin as an adjuvant therapy for depression. OBJECTIVE: To determine the effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder. METHODS: This randomized clinical trial was conducted at Kargarnejad Psychiatric Hospital in Kashan, Isfahan, Iran, from September 1, 2016 to November 1, 2016. The study participants included 100 patients with major depressive disorder who were assigned to aspirin and placebo groups by the use of computer-generated random numbers. Patients in these groups respectively received sertraline-aspirin and sertraline-placebo for eight consecutive weeks. Patients were prescribed 80 milligrams of aspirin twice a day. Also, sertraline was administered at a dose of 50-200 milligrams daily. Beck Depression Inventory was employed for depression severity assessment at four time points, namely before, two, four, and eight weeks after the beginning of the intervention. Medication side effects were also assessed eight weeks after the beginning of the intervention. Data were analyzed by SPSS version 12.0, using Chi-square and the Independent-samples t-test (α=0.05). RESULTS: Both groups were matched in terms of age (p=0.46), gender (p=0.539), and depression severity (p=0.509, with mean score 33.5±4.1 vs. 32.8±5.9) at baseline. However, depression scores were reduced significantly four and eight weeks after initiation of therapy just in the sertraline-aspirin group (p<0.05). CONCLUSION: As an adjuvant therapy, aspirin can reduce depression severity among patients with major depressive disorder. Yet, further studies are needed to prove the effectiveness of aspirin and other anti-inflammatory agents in reducing depression severity. TRIAL REGISTRATION: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the IRCT ID: IRCT2016082829556N1. FUNDING: The authors received financial support from Research Deputy of Kashan University of Medical Sciences, Kashan, Isfahan, Iran
Authors and Affiliations
Zahra Sepehrmanesh, Hosein Fahimi, Goudarz Akasheh, Mohamadreza Davoudi, Hamidreza Gilasi, Amir Ghaderi
Keywords
Related Articles
- EP ID EP333035
- DOI 10.19082/5770
- Views 111
- Downloads 0
The Abortificient Effects of Hydroalcoholic Extract of Lawsonia Inermis on BALB/c Mice
INTRODUCTION: According to the traditional beliefs of certain cultures, Lawsonia inermis has been reported to cause the abortion or termination of an undesirable pregnancy. The present study was undertaken with the goal...
Measuring the Efficiency of a Hospital based on the Econometric Stochastic Frontier Analysis (SFA) Method.
Hospitals are the most expensive health services provider in the world. Therefore, the evaluation of their performance can be used to reduce costs. The aim of this study was to determine the efficiency of the hospitals a...
The comparison of frequency of the upper limb musculoskeletal disorders among patients with diabetes type II with normal cases
BACKGROUND AND AIM: Musculoskeletal disease, that is recognized in diabetes and diabetes mellitus (DM) has shown a higher prevalence of chronic musculoskeletal complications. This study aimed at assessing the frequency o...
Efficacy of combination of Viola odorata, Rosa damascena and Coriandrum sativum in prevention of migraine attacks: a randomized, double blind, placebo-controlled clinical trial
BACKGROUND: Migraine is the second most common type of headache after tension headaches. In Iranian traditional medicine several herbal drugs are used for the treatment of headache. Including, a product of Iranian tradit...
Pattern and factors associated with cardiovascular diseases among patients attending the cardiac center in Arar City, Northern Saudi Arabia
BACKGROUND: Cardiovascular diseases (CVD) are among the main causes of premature death and hospital admission worldwide, constituting a great economic burden on health care systems. Additionally, thyroid diseases may exe...